Independent Reporting on AASLD 2015

AASLD 15 Main Page- Banner2

About the Program

Program Overview

The Advances in Chronic Hepatitis C: Management and Treatment program is a comprehensive, expert review of the 66th American Association for the Study of Liver Diseases Annual Meeting (AASLD 2015). This program consists of four components: (1) CME Internet Symposium: AASLD 2015 Expert Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) CME Internet Symposium: European Perspective on AASLD 2015: a 1-hour Internet symposium featuring Europe-based expert faculty reviewing and discussing key presentations with a focus on management and treatment in the EU; (3) CME Internet Symposium: Brazilian Perspective on AASLD 2015: a 1-hour Internet symposium featuring Brazil-based expert faculty reviewing and discussing key presentations with a focus on management and treatment in Brazil and (4) Rapid-Fire Review of AASLD 2015: a podcast that provides a brief, audio summary of the essential data presented at the conference, and (5) From Conference to Clinic: Reviewing and Applying Data from AASLD 2015: case based dinner meetings during which the key data are reviewed, discussed and applied to patient care

This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at AASLD 2015 and it is not sanctioned by the organizers of AASLD 2015.

Media: Internet

Back to Top

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HCV infection.

Back to Top

Learning Objectives

After completing these activities, participants should be better able to:

  • Use in a clinical setting important findings from key studies on CHC diagnosis and treatment presented at AASLD 2015
  • Employ current treatment protocols for CHC in clinical practice, including the studies and data presented at AASLD 2015 to improve patient care
  • Engage patients and colleagues in discussion on studies and data presented at AASLD 2015 relevant to new therapies for CHC to determine the appropriate treatment for patients with CHC

Faculty

Nezam H. Afdhal, MD
Professor of Medicine
Harvard School of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Maria Buti, MD, PhD
Professor of Medicine
Chief of Internal Medicine and Hepatology
Hospital General Universitari Valle Hebron
Barcelona, Spain

Douglas T. Dieterich, MD
Professor of Medicine and Director of CME
Department of Medicine
Director of Outpatient Hepatology
Division of Liver Diseases
Mount Sinai School of Medicine
New York, New York

Paul Kwo, MD
Professor of Medicine
Medical Director, Liver Transplantation
Division of Gastroenterology and Hepatology
Indiana University School of Medicine
Indianapolis, Indiana

Professor Jean-Michel Pawlotsky, MD, PhD
Director, National Reference Center for Viral Hepatitis B, C and Delta
Head, Department of Virology, Henri Mondor Hospital
University of Paris-Est and INSERM U955
Creteil, France

Mário G. Pessoa, MD, PhD
Assistant Professor
Division of Gastroenterology and Hepatology
University of São Paulo School of Medicine
São Paulo, Brazil

Fred Poordad, MD
VP, Academic and Clinical Affairs
The Texas Liver Institute
Clinical Professor of Medicine
University of Texas Health Science Center
San Antonio, Texas

K. Rajender Reddy, MD
Ruimy Family President's Distinguished Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director, Viral Hepatitis Center
University of Pennsylvania
Philadelphia, Pennsylvania

Jürgen Rockstroh, MD
Professor of Medicine
Department of Medicine I
University Hospital
Bonn, Germany

Mauro Schechter, MD, PhD
Professor of Infectious Diseases
Department of Preventive Medicine
Federal University of Rio de Janeiro, Brazil
Rio de Janeiro, Brazil

Mark Sulkowski, MD
Professor of Medicine and Medical Director
Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Hugo Cheinquer, MD, PhD 
Associate Professor of Gastroenterology and Hepatology 
Universidade Federal do Rio Grande do
Sul School of Medicine
Porto Alegre, RS, Brazil

Alessio Aghemo, MD, PhD 
Division of Gastroenterology and Hepatology 
Fondazione IRCCS Ca' Granda,
Ospedale Maggiore Policlinico
Universita degli Studi di Milano
Milan, Italy

Paul J Pockros, MD
Head, Division of Gastroenterology/Hepatology 
Drector, SC Liver Research Consortium
The Scripps Clinic
La Jolla, California 

Back to Top

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians. 

Back to Top

Credit Designation

On-Demand Internet Symposium - AASLD 2015 Expert Review

The Postgraduate Institute for Medicine designates this enduring material for a maximum 2.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

On-Demand Internet Symposium: European Perspective on AASLD 2015

The Postgraduate Institute for Medicine designates this enduring material for a maximum 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

On-Demand Internet Symposium: Brazillian Perspective on AASLD 2015

The Postgraduate Institute for Medicine designates this enduring material for a maximum 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Comprehensive Expert Review and Discussion of Key Presentations

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

There will be 8 posters and presentations available for a total of 2.0 possible credit hours.

Rapid-Fire Review of AASLD 2015

The Postgraduate Institute for Medicine designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Instructions for Participation and Credit

On-Demand Internet Symposium: AASLD 2015 Expert Review

There are no fees for participating and receiving CME credit for this activity. During the period, December 3, 2015 through December 3, 2016, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 10512.  Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

On-Demand Internet Symposium: European Perspective on AASLD 2015

There are no fees for participating and receiving CME credit for this activity. During the period, December 15, 2015 through December 15, 2016, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 10648. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

On-Demand Internet Symposium: Brazillian Perspective on AASLD 2015

There are no fees for participating and receiving CME credit for this activity. During the period, December 15, 2015 through December 15, 2016, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 10853. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Comprehensive Expert Review and Discussion of Key Presentations

There are no fees for participating and receiving CME credit for this activity. During the period, November 3, 2015 through November 3, 2016, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 11317.  Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Rapid-Fire Reivew from AASLD 2015 (Audio Podcast)

There are no fees for participating and receiving CME credit for this activity. During the period, November 19, 2015 through November 19, 2016, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 10647.  Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year. 

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to provideing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commerical interest. 

Back to Top

Nezam Afdhal, MD

  • Consulting Fees: Merck, Gilead, Echosens, GSK, Ligand, Springbank, Kadmon, Janssen, Abbvie, Achillion, Sandhill Scientific
  • Research Support: Merck, Vertex, Gilead, Abbvie, BMS
  • Ownership Interest:Springbank
  • Other: Editor, Journal of Viral Hepatitis

Maria Buti, MD

  • Consulting Fees: Gilead, Merck, Janssen

Doug Dieterich, MD

  • Consulting Fees: Gilead, BMS, Merck, Achillion, Abbvie
  • Fees for Non-CME/CE Services: Gilead, BMS, Merck, Achillion, Abbvie
  • Contracted Research: Gilead, BMS, Merck, Achillion, Abbvie

Paul Kwo, MD

  • Consulting Fees: Abbvie, BMS, Gilead, Merck, Janssen
  • Contracted Research: Abbvie, BMS, Gilead, Merck, Janssen

Jean-Michel Pawlotsky, MD

  • Consulting Fees: Gilead, Merck, Janssen

Mario Pessoa, MD

  • Consulting Fees: Abbvie, Roche, Janssen, BMS, Gilead, Merck
  • Fees for Non-CME/CE Services: Abbvie, Roche, Janssen, BMS, Gilead, Merck
  • Contracted Research: Abbvie

Fred Poordad, MD

  • Consulting Fees: Abbvie, Achillion, Anadys, Biolex, BI, BMS, Gilead, GSK, Globelmmune, Idenix, Merck, Novartis, Tibotec/Janssen, Theravance, Vertex
  • Fees for Non-CME/CE Services: Gilead, Kadmon, Merck, Onyx/Bayer, Genentech, GSK, Salix, Vertex
  • Research Support: Abbvie, Achillion, Anadys, Biolex, BI, BMS, Genentech, Gilead, GSK, Globelmmune, Idenix, Idera, Intercept, Janssen, Medarex, Medtronic, Merck, Novartis, Santaris, Scynexis, Vertex, ZymoGenetics

K. Rajender Reddy, MD

  • Consulting Fees: Abbive, Janssen, BMS, Merck, Gilead
  • Contracted Research: Abbive, Janssen, BMS, Merck, Gilead (to UPenn)

Juergen Rockstroh, MD

  • Consulting Fees: Abbvie, Bionor, BMS, Gilead, Janssen, Merck, ViiV
  • Fees for Non-CME/CE Services: Abbvie, BMS, Gilead, Janssen, Merck, ViiV
  • Contracted Research: Gilead

Mauro Schechter, MD

  • Consulting Fees: Achillion, BMS, Gilead, Abbvie, Merck, Janssen, Roche

Mark Sulkowski, MD

  • Contracted Research: Abbvie, BMS, Janssen, Gilead, Merck
  • Consulting Fees: Achillion, Abbvie, BMS, Janssen, Gilead

Hugo Cheinquer, MD, PhD

  • Consulting Fees: BMS, Gilead, AbbVie, Janssen
  • Fees for Non-CME/CE Services: BMS, Gilead, AbbVie, Janssen
  • Contracted Research: AbbVie

Alessio Aghemo, MD, PhD

  • Consulting Fees: Gilead, AbbVie, BMS, MSD, Janssen
  • Contracted Research: Gilead

Paul Pockros, MD

  • Consulting Fees: AbbVie, Janssen, BMS, Merck, Gilead
  • Contracted Research: AbbVie, Janssen, BMS, Merck, Gilead
Back to Top

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. 

Back to Top

    PIM_small

 

This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs and Merck & Co., Inc.

This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.

 

*Greenwich Mean Time

 

Back to Top

 

     

Prepare to print

Share this page:

Get link code to this page     


Back to Top